Raymond James Financial Inc. Acquires 48,901 Shares of Alignment Healthcare, Inc. $ALHC

Raymond James Financial Inc. boosted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 31.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 206,174 shares of the company’s stock after purchasing an additional 48,901 shares during the quarter. Raymond James Financial Inc. owned about 0.10% of Alignment Healthcare worth $3,839,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock valued at $206,941,000 after purchasing an additional 1,295,825 shares during the period. Wellington Management Group LLP boosted its stake in Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the period. Millennium Management LLC boosted its stake in Alignment Healthcare by 588.3% during the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the period. Invesco Ltd. boosted its stake in Alignment Healthcare by 1,415.7% during the 1st quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock valued at $34,927,000 after purchasing an additional 1,752,033 shares during the period. Finally, Point72 Asset Management L.P. bought a new stake in Alignment Healthcare during the 4th quarter valued at approximately $20,087,000. Institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ALHC shares. Barclays raised Alignment Healthcare from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $9.00 to $13.00 in a report on Thursday, July 31st. Zacks Research raised Alignment Healthcare to a “hold” rating in a report on Friday, August 8th. Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. KeyCorp raised Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a report on Monday, August 25th. Finally, Stephens raised Alignment Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $18.83.

Insiders Place Their Bets

In other news, insider Robert L. Scavo sold 60,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the completion of the transaction, the insider directly owned 642,953 shares of the company’s stock, valued at approximately $9,387,113.80. This represents a 8.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO John E. Kao sold 180,000 shares of the stock in a transaction that occurred on Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the sale, the chief executive officer owned 1,553,100 shares in the company, valued at approximately $20,827,071. This trade represents a 10.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 636,185 shares of company stock worth $9,235,468 in the last 90 days. 7.00% of the stock is owned by corporate insiders.

Alignment Healthcare Trading Down 2.7%

Shares of ALHC opened at $15.86 on Friday. Alignment Healthcare, Inc. has a 1 year low of $8.65 and a 1 year high of $21.06. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a 50 day simple moving average of $14.18 and a 200-day simple moving average of $15.43. The stock has a market cap of $3.14 billion, a PE ratio of -56.64 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $960.25 million. During the same period in the prior year, the firm posted ($0.13) EPS. Alignment Healthcare’s quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.